Related Experiment Video
Updated: Mar 13, 2026

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins
Published on: June 11, 2015
Characterization of novel Staphylococcus aureus lytic phage and defining their combinatorial virulence using the
Luis A Estrella1, Javier Quinones1, Matthew Henry1
1Biological Defense Research Directorate, Naval Medical Research Center-Frederick , Fort Detrick, MD USA.
Abstract:
Skin and soft tissue infections (SSTI) caused by methicillin resistant Staphylococcus aureus (MRSA) are difficult to treat. Bacteriophage (phage) represent a potential alternate treatment for antibiotic resistant bacterial infections. In this study, 7 novel phage with broad lytic activity for S. aureus were isolated and identified. Screening of a diverse collection of 170 clinical isolates by efficiency of plating (EOP) assays shows that the novel phage are virulent and effectively prevent growth of 70-91% of MRSA and methicillin sensitive S. aureus (MSSA) isolates. Phage K, which was previously identified as having lytic activity on S. aureus was tested on the S. aureus collection and shown to prevent growth of 82% of the isolates. These novel phage group were examined by electron microscopy, the results of which indicate that the phage belong to the Myoviridae family of viruses. The novel phage group requires β-N-acetyl glucosamine (GlcNac) moieties on cell wall teichoic acids for infection. The phage were distinct from, but closely related to, phage K as characterized by restriction endonuclease analysis. Furthermore, growth rate analysis via OmniLog® microplate assay indicates that a combination of phage K, with phage SA0420ᶲ1, SA0456ᶲ1 or SA0482ᶲ1 have a synergistic phage-mediated lytic effect on MRSA and suppress formation of phage resistance. These results indicate that a broad spectrum lytic phage mixture can suppress the emergence of resistant bacterial populations and hence have great potential for combating S. aureus wound infections.
Insights
Novel bacteriophages (phages) show promise for treating antibiotic-resistant Staphylococcus aureus infections. A combination of phages effectively reduces bacterial growth and prevents resistance, offering a potential new therapy for skin infections.
Area of Science:
- Microbiology
- Virology
- Infectious Diseases
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) causes difficult-to-treat skin and soft tissue infections (SSTIs).
- Bacteriophages (phages) are viruses that infect bacteria and are being explored as an alternative to antibiotics for resistant infections.
Purpose of the Study:
- To isolate and characterize novel bacteriophages with lytic activity against Staphylococcus aureus, including MRSA.
- To evaluate the efficacy of these novel phages, individually and in combination, against clinical isolates of S. aureus.
- To investigate the potential of phage combinations to overcome phage resistance.
Main Methods:
- Isolation and identification of seven novel phages with broad lytic activity against S. aureus.
- Efficiency of plating (EOP) assays to screen 170 clinical isolates (MRSA and MSSA).
- Electron microscopy for phage morphology, restriction endonuclease analysis for genetic relatedness, and OmniLog® microplate assay for growth rate and synergy studies.
Main Results:
- The novel phages demonstrated virulent lytic activity, inhibiting 70-91% of MRSA and MSSA isolates.
- Phages belong to the Myoviridae family and require specific cell wall components for infection.
- Combinations of phage K with novel phages (SA0420ᶲ1, SA0456ᶲ1, SA0482ᶲ1) exhibited synergistic lytic effects and suppressed the emergence of phage resistance.
Conclusions:
- A broad-spectrum lytic phage mixture effectively combats S. aureus, including resistant strains.
- Phage combinations can suppress the development of bacterial resistance, a significant challenge in phage therapy.
- These findings highlight the potential of phage therapy for treating S. aureus wound infections.
More Related Videos
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
09:23Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics
Published on: January 5, 2024
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Viral Replication: Lytic Cycle
Viral Replication: Lysogenic Cycle
DNA Bacteriophages
Gene Regulation in Microbial Communities: Quorum Sensing